GL1X · GenesisL1 explorer

MolNFT v1 · #116423 · protein

Crystal structures in an anti-HIV antibody lineage from immunization of rhesus macaques

5DD6 · Anti-HIV antibody DH570.MUT58 Fab heavy chain: “Crystal structures in an anti-HIV antibody lineage from immunization of rhesus macaques”. X-ray diffraction, 7 pockets (best druggability 0.68). MolNFT v1 #116423 on GenesisL1: 3D…

PDB
5DD6
Type
protein
Length
858 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Anti-HIV antibody DH570.MUT58 Fab heavy chain; Anti-HIV antibody DH570.MUT58 Fab light…
Pockets
7 · best druggability 0.68

Structure

x-ray diffraction · 3 distinct chains · 7% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HAnti-HIV antibody DH570.MUT58 Fab heavy chainprotein2198% helix, 55% strand—
L, BAnti-HIV antibody DH570.MUT58 Fab light chainprotein2136% helix, 51% strand—
AAnti-HIV antibody DH570.MUT58 Fab heavy chainprotein2136% helix, 54% strand—

Pockets

7 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19840.680.74104empty
22630.480.7334empty
32440.470.7342empty
4690.460.8320empty
51190.420.7623empty

Interfaces

5 interfaces between chains.

  • H–L · 1882 Ų buried · 11 hydrogen bonds · protein-protein
  • A–B · 1769 Ų buried · 7 hydrogen bonds · protein-protein
  • H–B · 98 Ų buried · 1 hydrogen bond · protein-protein
  • L–B · 97 Ų buried · 1 hydrogen bond · protein-protein
  • L–A · 56 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 5DD6 · Crystal structures in an anti-HIV antibody lineage from immunization of Rhesus macaques · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.